NCT03790748

Brief Summary

This study will be conducted on 273 patients of ASA grade I and II aged from 25 to 55 years and presented for elective vaginal surgeries such as vaginal hysterectomy, repair of prolapse Patients will be divided into three equal groups; group A control group for conventional epidural technique(n=91), group B for dural puncture epidural with 27G pencil point Whitacre spinal needle (n=91) and group C for dural puncture epidural with 25G pencil point Whitacre spinal needle(n=91). Randomization will be done using computer generated number and concealed using sequentially numbered sealed opaque envelope.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
273

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 2, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

2.4 years

First QC Date

December 23, 2018

Last Update Submit

August 27, 2021

Conditions

Keywords

Neuraxial Technique, Epidural Technique, Dural Puncture Epidural Technique, Gynecologic Disease

Outcome Measures

Primary Outcomes (1)

  • incidence of bilateral sacral blockade

    Sensory blockade was evaluated using a non-traumatic pinprick stimulus starting at the S2 dermatome and moving in a caudad direction (measured every 2 minutes)

    Up to 30 minutes after local anesthetic injection

Secondary Outcomes (12)

  • Onset of sensory blockade

    Up to 30 minutes after local anesthetic injection

  • Maximum achieved sensory level

    Up to 30 minutes after local anesthetic injection

  • Time to achieve the maximum sensory level

    Up to 30 minutes after local anesthetic injection

  • Onset of motor blockade

    Up to 30 minutes after local anesthetic injection

  • Time to complete motor block

    Up to 30 minutes after local anesthetic injection

  • +7 more secondary outcomes

Study Arms (3)

Conventional Epidural Technique

EXPERIMENTAL

Procedure: Standard Lumbar Epidural Block using Touhy Epidural Needle (18G) at L4-5 inter-space and Epidural Catheter (20G) was inserted then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.

Procedure: 25G Dural Puncture Epidural TechniqueProcedure: 27G Dural Puncture Epidural Technique

Dural Puncture Epidural Technique using pencil-point 25G Whitacre needle

ACTIVE COMPARATOR

Procedure: 25G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.

Procedure: Standard Lumbar Epidural TechniqueProcedure: 27G Dural Puncture Epidural Technique

Dural Puncture Epidural Technique using pencil-point 27G Whitacre needle

ACTIVE COMPARATOR

Procedure: 27G Dural Puncture Epidural Block at L4-5 inter-space then bupivacaine 0.5% 15-20 ml with 50ug fentanyl was given.

Procedure: Standard Lumbar Epidural TechniqueProcedure: 25G Dural Puncture Epidural Technique

Interventions

Standard Lumbar Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.

Dural Puncture Epidural Technique using pencil-point 25G Whitacre needleDural Puncture Epidural Technique using pencil-point 27G Whitacre needle

25G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.

Conventional Epidural TechniqueDural Puncture Epidural Technique using pencil-point 27G Whitacre needle

27G Dural Puncture Epidural Technique at L4-5 inter-space using 0.5%Bupivacaine and Fentanyl.

Conventional Epidural TechniqueDural Puncture Epidural Technique using pencil-point 25G Whitacre needle

Eligibility Criteria

Age25 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I and II
  • Height(150-170 cm)

You may not qualify if:

  • patient refusal
  • hypersensitivity to local anesthetic drugs
  • bleeding disorders and coagulopathy(platelets count less than 80000,INR less than 1.5 or therapeutic dose of anticoagulant).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Department of Anesthesia, Surgical ICU, and Pain Management

Cairo, 11562, Egypt

Location

Reham Ali Abdelrahman

Cairo, 11562, Egypt

Location

MeSH Terms

Conditions

Genital Diseases, Female

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Reham Ali Abdelrahman, M.D.

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia

Study Record Dates

First Submitted

December 23, 2018

First Posted

January 2, 2019

Study Start

February 1, 2019

Primary Completion

June 28, 2021

Study Completion

July 31, 2021

Last Updated

September 1, 2021

Record last verified: 2021-08

Locations